Unknown PHASE4 INTERVENTIONAL 2-arm NCT00732511

Coreg CR, Blood Vessel Stiffness and Blood Vessel Function

Effect of Coreg CR on BP, Endothelial Function, Exhaled Nitric Oxide, and Nitric Oxide Production and Oxidation

Sponsor: State University of New York - Downstate Medical Center

Conditions Diabetes Mellitus Endothelial Function Hypertension

Interventions carvedilol metoprolol extended release

Updated 6 times since 2017 Last updated: Feb 9, 2011 Started: Apr 30, 2008 Primary completion: Dec 31, 2008 Completion: Apr 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Diabetes Mellitus and Endothelial Function, this trial is ongoing. The trial is conducted by State University of New York - Downstate Medical Center and has accumulated 6 data snapshots since 2008. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE4

First recorded

Apr 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

State University of New York - Downstate Medical Center

Data source: State University of New York - Downstate Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brooklyn, United States